Biomerica, Inc. BMRA
Set alert
As of Nov 2, 11:32 AM ET
- YTD
- -30.16%
- 1 year
- -36.23%
- Open
- 1.77
- Prev close
- 1.72
- Mkt cap
- 7.89M
- Vol
- 2.04K
- Avg vol
- 71.58K
- EPS
- -1.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.72
- High
- 1.77
- Forward P/E
- 0.71
- Beta
- -1.14
- Short ratio
- 0.76
- Inst. own
- 12.36%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 21, 2025
- 50-d avg
- 0.3326
- 200-d avg
- 0.48235
- 1y target
- 0.00
News
2 weeks ago globenewswire.com
Biomerica Reports First Quarter Fiscal 2027 Financial Results
IRVINE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) ("Biomerica" or the "Company") today reported financial results for the first quarter of fiscal 2027, ended August 31,…
-
2 weeks ago benzinga.com
Biomerica Q1 EPS $(0.37), Sales $1.265M Down From $1.380M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.37) per share. The company reported $1.265 million in sales this quarter. This is a 8.33 percent decrease over sales of $1.380 million the…
-
1 month ago benzinga.com
Biomerica Files $250M Shelf Registration Statement For Mixed Securities Offering
BIOMERICA, INC. $250,000,000 Common StockPreferred StockDebt SecuritiesWarrants We may offer and sell the securities identified above from time to time in one or more offerings, in amounts, at prices…
-
1 month ago benzinga.com
Biomerica Files Prospectus Covering Resale Of Up To 1,403,705 Shares Of Common Stock By Selling Stockholders
BIOMERICA, INC. 1,403,705 Shares of Common Stock This prospectus relates to the proposed resale or other disposition by the selling stockholders identified in this prospectus of up to 1,403,705…
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma…
1 month ago defenseworld.net
Head-To-Head Survey: Biomerica (NASDAQ:BMRA) versus Cytosorbents (NASDAQ:CTSO)
Cytosorbents (NASDAQ: CTSO - Get Free Report) and Biomerica (NASDAQ: BMRA - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
-
2 months ago benzinga.com
Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.38) per share. This is a 44.93 percent increase over losses of $(0.69) per share from the same period last year. The company reported $875.000…
2 months ago globenewswire.com
Biomerica Reports Fiscal 2026 Year-End Financial Results
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2026 (“Fiscal 2026”).
2 months ago benzinga.com
Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer Acquires Pool Builder Geek and Poologics.
-
2 months ago benzinga.com
Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share
Biomerica, Inc. (NASDAQ:BMRA) ("Biomerica" or the "Company"), a developer and manufacturer of diagnostic test systems, today announced that it has entered into definitive agreements with institutional
2 months ago globenewswire.com
Biomerica Announces $2.23 Million Financing
IRVINE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (“Biomerica” or the “Company”), a developer and manufacturer of diagnostic test systems, today announced that it has…
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
5 months ago globenewswire.com
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream…
6 months ago globenewswire.com
Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago Real-world clinical…
-
6 months ago benzinga.com
Biomerica's Ethos Laboratories' Test Now Eligible For Medicare Coverage On Individual Basis Announced By Medicare Administrative Contractor
Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced that the Medicare Administrative Contractor (MAC) responsible for processing inFoods® IBS claims has…
6 months ago globenewswire.com
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under Existing $300 CMS Reimbursement Rate Company and Laboratory Partner Believe Properly Documented…
6 months ago globenewswire.com
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
— Represents Biomerica's First Commercial Entry into the Canadian Market for its Precision, Diagnostic-Guided Therapy — Canada Has One of the Highest IBS Prevalence Rates in the World — an Estimated…
-
6 months ago benzinga.com
Biomerica Q3 EPS $(0.44) Up From $(0.48) YoY, Sales $987.000K Down From $1.119M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.44) per share. This is a 8.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported $987.000…
6 months ago globenewswire.com
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the “Company”) a global provider of advanced medical diagnostic and therapeutic products today…
7 months ago defenseworld.net
Biomerica (BMRA) to Post Earnings on Monday
Biomerica (NASDAQ: BMRA - Get Free Report) is anticipated to post its results after the market closes on Monday, April 13th. Analysts expect Biomerica to post earnings of ($1.20) per share and…
-
7 months ago benzinga.com
Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test
First Commercial Order by Large Lab Chain: Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across Europe.Strategic…
7 months ago globenewswire.com
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced it has received its first…
8 months ago globenewswire.com
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great Britain Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic…
-
8 months ago benzinga.com
Biomerica Announces Responder Analysis Results From Ongoing Real-World Study Of inFoods IBS
Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company's…
8 months ago globenewswire.com
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with…
8 months ago defenseworld.net
Biomerica (NASDAQ:BMRA) Stock Passes Below 200 Day Moving Average – Here’s Why
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $2.67 and traded as low as…
8 months ago globenewswire.com
Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced that Vietnam's Hanoi Department of Health has…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
9 months ago globenewswire.com
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the…
9 months ago defenseworld.net
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Expands By 123.2%
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 92,289 shares, a…
10 months ago defenseworld.net
Biomerica (NASDAQ:BMRA) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $2.93 and traded as low…
-
10 months ago benzinga.com
Biomerica Says CMS Issues Final Pricing Determination For inFoods IBS Test, Establishing National Medicare Payment Rate Of $300 Under CLFS
CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure.The $300 rate will apply to claims approved and…
10 months ago globenewswire.com
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
IRVINE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, today announced that the Centers for Medicare & Medicaid Services…
10 months ago defenseworld.net
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next?
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $2.96 and traded as low as…
-
11 months ago benzinga.com
Biomerica Highlights Clinical Trial Showing inFoods IBS Test Significantly Reduces Symptoms Through Guided Dietary Therapy In The Fall 2025 Issue Of Biotherapeutics Quarterly, A Henry Schein Publication
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) --…
-
12 months ago benzinga.com
Biomerica Expands CDMO Services To Meet Rising Demand From Diagnostic And Biotech Companies
Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica's updated websiteIRVINE, Calif., Nov. 06, 2025…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
Biomerica Enters Marketing Partnership With Henry Schein To Promote Biomerica's Infoods Irritable Bowel Syndrome Test Across The United States, Excluding New York State
Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care…
-
1 year ago benzinga.com
Biomerica Partners With Henry Schein To Market Non-Drug IBS Test Nationwide
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization…
-
1 year ago benzinga.com
Biomerica Q1 Sales $1.380M Down From $1.807M YoY
Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decrease over sales of $1.807 million the same period last year.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
1 year ago benzinga.com
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
1 year ago benzinga.com
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session